Compare Enveric Biosciences Inc (ENVB) vs Oxford Lane Capital Corp (OXLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Oxford Lane Capital Corp — how do they compare? Enveric Biosciences Inc trades at $1.38 (market cap $5.32M), while Oxford Lane Capital Corp trades at $9.04 (market cap $881.29M). The key difference: Oxford Lane Capital Corp is far larger — about 165.7× Enveric Biosciences Inc's market cap, and Oxford Lane Capital Corp pays a 26.59% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | OXLC | |
|---|---|---|
Market Cap | $5.32M | $881.29M |
Sector | Health | Financials |
52-Week High | $17.40 | $20.75 |
52-Week Low | $1.28 | $8.15 |
Enterprise Value | $408.82K | — |
Dividend Yield | — | 26.59% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
OXLC trades at $9.035, down 1.04% with a bearish technical signal. The company reported negative earnings surprises in recent quarters, including a significant Q1 2026 miss, while maintaining a high dividend yield. Analyst sentiment is mixed with a 50% buy rating, but negative ROE and ROA raise concerns about financial health.
The outlook remains challenging with declining net asset value and operational cash flow deficits. While the high dividend yield attracts income investors, sustainability concerns persist given the negative profitability metrics and recent earnings underperformance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →
